XML 23 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholder's Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
LPC Offering
LPC Offering
Common Stock
LPC Offering
Additional Paid-In Capital
At The Market Offering
At The Market Offering
Common Stock
At The Market Offering
Additional Paid-In Capital
Beginning balance (in shares) at Dec. 31, 2018   65,290,879                  
Beginning balance at Dec. 31, 2018 $ 36,200 $ 1 $ 513,336 $ (475,667) $ (1,470)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock—restricted stock (in shares)   2,588,450                  
Issuance of common stock--option exercise (in shares)   34,669                  
Issuance of common stock—option exercise 121   121                
Issuance of common stock (in shares)   775,194                  
Issuance of common stock 3,000   3,000                
Compensation expense related to issued stock options and restricted stock awards 2,106   2,106                
Net loss (14,344)     (14,344)              
Other comprehensive income (loss) 218       218            
Ending balance (in shares) at Jun. 30, 2019   68,689,192                  
Ending balance at Jun. 30, 2019 27,301 $ 1 518,563 (490,011) (1,252)            
Beginning balance (in shares) at Mar. 31, 2019   67,880,664                  
Beginning balance at Mar. 31, 2019 30,387 $ 1 514,484 (483,248) (850)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock—restricted stock (in shares)   (1,335)                  
Issuance of common stock--option exercise (in shares)   34,669                  
Issuance of common stock—option exercise 121   121                
Issuance of common stock (in shares)   775,194                  
Issuance of common stock 3,000   3,000                
Compensation expense related to issued stock options and restricted stock awards 958   958                
Net loss (6,763)     (6,763)              
Other comprehensive income (loss) (402)       (402)            
Ending balance (in shares) at Jun. 30, 2019   68,689,192                  
Ending balance at Jun. 30, 2019 $ 27,301 $ 1 518,563 (490,011) (1,252)            
Beginning balance (in shares) at Dec. 31, 2019 70,427,400 70,427,400                  
Beginning balance at Dec. 31, 2019 $ 16,347 $ 1 521,356 (504,145) (865)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock—restricted stock (in shares)   3,657,838                  
Issuance of common stock—restricted stock 0                    
Ending balance (in shares) at Mar. 31, 2020   71,505,724                  
Ending balance at Mar. 31, 2020 $ 9,515 $ 1 523,265 (513,498) (253)            
Beginning balance (in shares) at Dec. 31, 2019 70,427,400 70,427,400                  
Beginning balance at Dec. 31, 2019 $ 16,347 $ 1 521,356 (504,145) (865)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock—restricted stock (in shares)   3,736,162                  
Issuance of common stock—restricted stock 2                    
Issuance of common stock (in shares)             1,200,000     740,043  
Issuance of common stock           $ 1,317   $ 1,317 $ 705   $ 705
Compensation expense related to issued stock options and restricted stock awards 1,611   1,611                
Net loss (11,488)                    
Other comprehensive income (loss) $ (51)       (51)            
Ending balance (in shares) at Jun. 30, 2020 76,103,605 76,103,605                  
Ending balance at Jun. 30, 2020 $ 8,443 $ 1 524,991 (515,633) (916)            
Beginning balance (in shares) at Mar. 31, 2020   71,505,724                  
Beginning balance at Mar. 31, 2020 9,515 $ 1 523,265 (513,498) (253)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock (in shares)             200,000     740,043  
Issuance of common stock           $ 174   $ 174 $ 707   $ 707
Compensation expense related to issued stock options and restricted stock awards 845   845                
Net loss (2,135)                    
Other comprehensive income (loss) $ (663)       (663)            
Ending balance (in shares) at Jun. 30, 2020 76,103,605 76,103,605                  
Ending balance at Jun. 30, 2020 $ 8,443 $ 1 $ 524,991 $ (515,633) $ (916)